Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal CancerMarinde J. G. Bond, Johannes J.M. Kwakman, Rutger‐Jan Swijnenburg et al.|JCO Clinical Cancer Informatics|2024Cited by 6